David Harrison, MD
Obstetrics & Gynecology · Braselton, GANPI 1619949039
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Shield Therapeutics Inc at 26.3% of the total. Reporting peaked in 2023 at $667 and has fallen 58.8% since, to $274 in 2025.
Across 107 payments — averaging $22.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shield Therapeutics Inc$642
- AbbVie$342
- Coopersurgical, Inc.$187
- Bayer$186
- Sumitomo Pharma America, Inc.$125
- Pfizer$106
- plus $851 from 20 others
What the payments were for
- Food & beverage$2,42799%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shield Therapeutics Inc | 12 | $642 |
| AbbVie(2 entities) | 18 | $342 |
| Coopersurgical, Inc. | 4 | $187 |
| Bayer | 13 | $186 |
| Sumitomo Pharma America, Inc. | 7 | $125 |
| Pfizer | 6 | $106 |
| Biogen | 4 | $101 |
| Astellas Pharma US Inc | 5 | $100 |
| Daiichi Sankyo Inc. | 6 | $86 |
| Hologic Sales And Service, LLC | 4 | $71 |
| Exeltis, USA Inc. | 4 | $71 |
| Mayne Pharma Commercial LLC | 3 | $70 |
| Myovant Sciences Inc. | 4 | $58 |
| Optumhealth Care Solutions, LLC | 2 | $33 |
| Roche Diagnostics Corporation | 2 | $31 |
| Baxter Healthcare | 2 | $31 |
| Vertex | 1 | $29 |
| Boston Scientific | 2 | $29 |
| Scynexis, Inc. | 1 | $26 |
| Therapeuticsmd, Inc. | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $19 |
| Minerva Surgical, Inc | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Meditrina | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,439 in reported general payments places this provider in the 75th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 36 | $2,326 |
| Estradiol (Twice Weekly)Estradiol | 15 | $1,368 |
| Solifenacin Succinate | 24 | $1,025 |
| Fluconazole | 14 | $94 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Braselton
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
- Teresa ByrdMarietta$41K
- Christopher BassilSuwanee$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.